Hongyong He

机构：Fudan University, Zhongshan Hospital, Guizhou Provincial People's Hospital · ORCID：0000-0001-7371-4133

发表论文 82 篇 · 总被引 2629 次 · h-index 27

代表论文

• Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy (2022 · Cancer Immunology Immunotherapy · 被引 37)
• Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer (2022 · British Journal of Cancer · 被引 34)
• C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer (2023 · British Journal of Cancer · 被引 25)
• Complement receptor C5aR1 blockade reprograms tumor‐associated macrophages and synergizes with anti‐PD ‐1 therapy in gastric cancer (2023 · International Journal of Cancer · 被引 24)
• Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer (2023 · Journal for ImmunoTherapy of Cancer · 被引 23)
• Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer (2022 · Journal for ImmunoTherapy of Cancer · 被引 23)